Literature DB >> 10395328

Interleukin-4 receptor-directed cytotoxin therapy of AIDS-associated Kaposi's sarcoma tumors in xenograft model.

S R Husain1, R J Kreitman, I Pastan, R K Puri.   

Abstract

The elusive and enigmatic origin of AIDS-associated Kaposi's sarcoma (AIDS-KS) makes it a complex tumor and therefore difficult to treat. Here we demonstrate that AIDS-KS cells express surface interleukin-4 (IL-4) receptors, and that IL-4 toxin (IL-4(38-37)-PE38KDEL) is specifically cytotoxic to these cells. Intratumoral, intraperitoneal and intravenous administration of IL-4 toxin in nude mice with established subcutaneous AIDS-KS tumors caused considerable anti-tumor activity in a dose-dependent manner, with highest dose producing durable complete responses. Metabolic changes, including cachexia and lymphopenia, induced by KS tumors were prevented by IL-4 toxin treatment. This report establishes IL-4(38-37)-PE38KDEL as an experimental therapeutic agent for the treatment of AIDS-KS.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10395328     DOI： 10.1038/10541

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   87.241


  9 in total

1.  Controlling tumor-derived and vascular endothelial cell growth: role of the 4Ff2 cell surface antigen.

Authors:  M Papetti; I M Herman
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  A mathematical model of the impact of infused targeted cytotoxic agents on brain tumours: implications for detection, design and delivery.

Authors:  Lawrence M Wein; Joseph T Wu; Alexandra G Ianculescu; Raj K Puri
Journal:  Cell Prolif       Date:  2002-12       Impact factor: 6.831

3.  Hodgkin lymphoma therapy with interleukin-4 receptor-directed cytotoxin in an infiltrating animal model.

Authors:  Mariko Kawakami; Koji Kawakami; Mitomu Kioi; Pamela Leland; Raj K Puri
Journal:  Blood       Date:  2004-12-30       Impact factor: 22.113

4.  Constitutive Activation of Interleukin-13/STAT6 Contributes to Kaposi's Sarcoma-Associated Herpesvirus-Related Primary Effusion Lymphoma Cell Proliferation and Survival.

Authors:  Chong Wang; Caixia Zhu; Fang Wei; Liming Zhang; Xiaohui Mo; Yanling Feng; Jianqing Xu; Zhenghong Yuan; Erle Robertson; Qiliang Cai
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

Review 5.  Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy.

Authors:  Mariko Kawakami; Koji Kawakami; Raj K Puri
Journal:  J Neurooncol       Date:  2003-10       Impact factor: 4.130

6.  IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein.

Authors:  B H Joshi; P Leland; J Silber; R J Kreitman; I Pastan; M Berger; R K Puri
Journal:  Br J Cancer       Date:  2002-01-21       Impact factor: 9.075

7.  Identification of a novel role of IL-13Rα2 in human Glioblastoma multiforme: interleukin-13 mediates signal transduction through AP-1 pathway.

Authors:  Rukmini Bhardwaj; Akiko Suzuki; Pamela Leland; Bharat H Joshi; Raj K Puri
Journal:  J Transl Med       Date:  2018-12-20       Impact factor: 5.531

8.  Iron: a target for the management of Kaposi's sarcoma?

Authors:  Thierry Simonart
Journal:  BMC Cancer       Date:  2004-01-15       Impact factor: 4.430

9.  Interleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the disease.

Authors:  Bharat H Joshi; Pamela Leland; Samir Lababidi; Frederick Varrichio; Raj K Puri
Journal:  Cancer Med       Date:  2014-09-10       Impact factor: 4.452
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.